Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.
2.
3.
5.

Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity.

Fan JD, Wagner BL, McDonnell DP.

Mol Endocrinol. 1996 Dec;10(12):1605-16. Erratum in: Mol Endocrinol 1997 Mar;11(3):341.

PMID:
8961270
6.
7.
8.

Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.

Zou A, Marschke KB, Arnold KE, Berger EM, Fitzgerald P, Mais DE, Allegretto EA.

Mol Endocrinol. 1999 Mar;13(3):418-30.

PMID:
10076999
9.

The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens.

Montano MM, Katzenellenbogen BS.

Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2581-6.

10.

Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.

Steinmetz R, Young PC, Caperell-Grant A, Gize EA, Madhukar BV, Ben-Jonathan N, Bigsby RM.

Cancer Res. 1996 Dec 1;56(23):5403-9.

11.

Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation.

Oesterreich S, Zhang Q, Hopp T, Fuqua SA, Michaelis M, Zhao HH, Davie JR, Osborne CK, Lee AV.

Mol Endocrinol. 2000 Mar;14(3):369-81.

PMID:
10707955
13.

Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway.

Jakacka M, Ito M, Weiss J, Chien PY, Gehm BD, Jameson JL.

J Biol Chem. 2001 Apr 27;276(17):13615-21. Epub 2001 Jan 18.

14.

Tamoxifen agonism and estrogen antagonism of c-fos gene promoter activity through non-consensus-responsive elements in MC3T3-E1 osteoblasts.

Ishibashi O, Yamagishi T, Hanada K, Kawashima H.

Biochem Biophys Res Commun. 2001 Dec 7;289(3):705-11.

PMID:
11726205
15.
16.
17.

Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.

Lee AV, Weng CN, Jackson JG, Yee D.

J Endocrinol. 1997 Jan;152(1):39-47.

PMID:
9014838
18.

Peptide antagonists of the human estrogen receptor.

Norris JD, Paige LA, Christensen DJ, Chang CY, Huacani MR, Fan D, Hamilton PT, Fowlkes DM, McDonnell DP.

Science. 1999 Jul 30;285(5428):744-6.

19.

Functional antagonism between the estrogen receptor and Fos in the regulation of c-fos protooncogene transcription.

Ambrosino C, Cicatiello L, Cobellis G, Addeo R, Sica V, Bresciani F, Weisz A.

Mol Endocrinol. 1993 Nov;7(11):1472-83.

PMID:
8114761
20.

Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells.

Wang Z, Kyo S, Maida Y, Takakura M, Tanaka M, Yatabe N, Kanaya T, Nakamura M, Koike K, Hisamoto K, Ohmichi M, Inoue M.

Oncogene. 2002 May 16;21(22):3517-24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk